You read my 2014 biotech stock predictions yesterday. (Well, I hope you did.) Today, it's Biotech Twitter's turn to forecast the next 12 months.
Here's what you came up with:
@adamfeuerstein antibiotics cos. $CBST $CEMP $TTPH $MDCO go from red headed stepchild status to venerable Cinderellas ala onco, orphan stks
Vikram Khanna (@VikramKhanna_) January 7, 2014
@adamfeuerstein FDA will change stance. Allow $SRPT to file for AA. The hitch? So can $RNA $GSK.
Philip (@Qbert2600) January 6, 2014 @adamfeuerstein My old love $OXGN could be a 10 bagger this year.. I believe Zybrestat + Avastin could be meaningful combo in ovarian cancer
nuere (@nuere) January 3, 2014 @adamfeuerstein big cap pharma and biotech form a cartel, buy express scripts & fire the ceo ti show him he's not the boss of them
dino perlman (@DinoPerlman) January 3, 2014 @adamfeuerstein $snta Galaxy 2 interim this year will look like a riddle. no accountability,sending pumpers into a frenzy and future letdown
BATTLE THE BTK (@BioWino) January 3, 2014 @adamfeuerstein $ssh gets eu approval. initial us results positive. goes to $12-13 by june. ends year at $14.
Mark Dimont (@mdimont) January 3, 2014 @adamfeuerstein Merck AG buys THLD for 10 USD a share
Martin Burda (@capitalinked) January 3, 2014 @adamfeuerstein MACK at least a double from here by Q-2.
Eric Zakarin (@EricZakarin) January 3, 2014 @adamfeuerstein $halo triple with a buyout
FinansciCenk (@FinansciCenk) January 3, 2014 @adamfeuerstein 2014 biotech prediction: Market finally wakes up and figures out that turds float. Forever.
BioTurdCEO (@BioTurdCEO) January 3, 2014 @adamfeuerstein $ATHX to $10 or more, $INO to $6 or more and $AMBS to .50 or more, followed by r/s and uplist to Nasdaq.
Joshua Emberlin (@joshuaemberlin) January 3, 2014 @adamfeuerstein $vrtx to $120, $bmy once again top large cap. $srpt runs then tanks again on delayed filing, $iphyf big gainer.
Chris Ahlstrand (@ahlstrac) January 3, 2014 @adamfeuerstein $BLUE $FMI and $TKMR will perform extremely well as part of a growing genetic medicine trend but $ALNY will dip considerably
Gonzo von Loob (@GonzoVonLoob) January 3, 2014 @DinoPerlman @adamfeuerstein npsp gets acquired by who do you think?
Dr. Paul DeSantis (@DrPaulyDeSantis) January 3, 2014 @Skipjackrick @adamfeuerstein people $mnkd is getting approved...pic this your at the doctors office u have diabetes. Shots ? Or inhale ?
Eric Fenar (@Peakabull) January 3, 2014 @adamfeuerstein My 2014 prediction is you finally get nailed for stock manipulation and end up in jail with Andrew Left and Martin Shkreli.
John Stiles (@JohnStiles10) January 6, 2014 More of your biotech stock prediction tweets on the next page.
@adamfeuerstein $SRPT makes a comeback; $VRTX goes over $100 on CF data; ARWR top gainer on HepB HK results; $CHTP finally gets approval
steve engen (@seetokyo) January 2, 2014 @adamfeuerstein $halo doubles and $amrn sub $1
mdh (@mdholmstrom79) January 2, 2014 @adamfeuerstein 6-month FEV1 data from VX-809 combo ph3 will impress and prove those who were skeptical based on '56 day' data WRONG.
avidresearch (@avidresearch) January 2, 2014 . @adamfeuerstein forgot $exel fails to meet endpoints and everyone loses (more) $ COMET
daviesbj (@daviesbj) January 6, 2014 @adamfeuerstein Biopredictions 2014 $GALE $ATHX whiff; $ARRY $GERN partner or b/o; $MNKD fail; $ACHN sopa hold lifted; $EXAS ColoG approval
S Manian (@DrSManian) January 6, 2014 @adamfeuerstein $MNTA attains and holds sole approval of interchangeable generic copaxone for duration of the 2014
JNB (@pollyvonwog) January 2, 2014 @adamfeuerstein Lou Gehrig smiles from above as $CUR approach works
Thomas Lynch (@doors1967_2000) January 2, 2014 @adamfeuerstein I personally believe $MNKD will have another great run up into the PDUFA but ultimately no approval IMO.
Richard Underbrink (@Skipjackrick) January 2, 2014 @adamfeuerstein $gern buyout or partnership
Joel Thomson (@JSTBiotech) January 6, 2014 @adamfeuerstein AMGN buys UCB
San (@LukatonMateo) January 5, 2014 @adamfeuerstein $CYTK ALS trial +ve trend but not stat sig. $AMGN starts p3 of OM. $EXEL +ve p3, $INCY acquired $THRX acquired by $GSK
Juan P. Serrate, DVM (@JPZaragoza1) January 5, 2014 @adamfeuerstein Possible takeover candidates 2014: $bmrn $jazz $halo $cemp $amrn $tgtx. I'm willing to believe 2 of these may go b4 EOY.
Joe (@Drchik23) January 3, 2014 @adamfeuerstein Exciting progress with imuno-onc $BMY Nivo / Nivo+Ipi & same $MRK Lambro / Lambro+carb/cisp both reaching >$60 during 2014
Joe (@GantosJ) January 5, 2014 @adamfeuerstein $NLNK Phase III Algenpantucel-L fail
Dion Capital (@DionCapital) January 6, 2014 @adamfeuerstein $ALNY buys $TKMR and private Pharma Royalty Co tries to takeover $LGND, but fails in the end.
weltvermesser (@weltvermesser) January 6, 2014 @adamfeuerstein $MACK MM-398 data fails to meet primary endpoint in NAPOLI-1. I believe the control arm is kicking ass.
Richard Underbrink (@Skipjackrick) January 6, 2014 @adamfeuerstein $AEGR under $10 http://t.co/8R2vy1rM7P
Matt Berry (@MattBerry01) January 6, 2014 
